Preventive Effect of Chrysin on Bleomycin-Induced Lung Fibrosis in Rats

Inflammation

Volumn 37, Issue 6, 2014, Pages 2116-2124

  Kilic, Talat ^a   Ciftci, Osman ^a   Cetin, Asli ^a   Kahraman, Hasan ^b  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KSU Medical School   (Turkey)

Author keywords

antiinflammatory; bleomycin; chrysin; idiopathic pulmonary fibrosis; pulmonary fibrosis

Indexed keywords

ANTIOXIDANT; BLEOMYCIN; CHRYSIN; FLAVONOID;

ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; PULMONARY FIBROSIS; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLEOMYCIN; FEMALE; FLAVONOIDS; OXIDATIVE STRESS; PULMONARY FIBROSIS; RATS; RATS, WISTAR;

EID: 84937579921     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9946-6     Document Type: Article

References (41)

1. Raghu, G., H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, J.A. Lasky, et al. 2011. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 183: 788–824.
2. Gross, T.J., and G.W. Hunninghake. 2001. Idiopathic pulmonary fibrosis. New England Journal of Medicine 345: 517–525.
3. Dedon, P.C., and I.H. Goldberg. 1992. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chemical Research in Toxicology 5: 311–332.
4. Cottin, V. 2013. The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis. Respiratory Research 14(1): 5. doi:10.1186/1465-9921-14- S1-S5.
5. Mata, M., A. Ruíz, M. Cerdá, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo. 2003. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. European Respiratory Journal 22(6): 900–905.
6. Sogut, S., H. Ozyurt, F. Armutcu, et al. 2004. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. European Journal of Pharmacology 494: 213–220.
7. Yildirim, Z., Y. Turkoz, M. Kotuk, et al. 2004. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 11: 156–165.
8. Kilic, T., H. Parlakpinar, A. Polat, E. Taslidere, N. Vardi, E. Sarihan, H. Ermis, and K. Tanbag. 2014. Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats. Inflammation. doi:10.1007/s10753-014-9841-1.
9. Yildirim, Z., M. Kotuk, H. Erdogan, M. Iraz, M. Yagmurca, I. Kuku, and E. Fadillioglu. 2006. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. Journal of Pineal Research 40: 27–33.
10. Iraz, M., H. Erdogan, M. Kotuk, M. Yagmurca, T. Kilic, H. Ermis, E. Fadillioglu, and Z. Yildirim. 2006. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacological Research 53: 310–316.
11. Akgedik, R., S. Akgedik, H. Karamanli, S. Uysal, B. Bozkurt, D. Ozol, F. Armutcu, and Z. Yildirim. 2012. Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation 35(5): 1732–1741.
12. Ermis, H., H. Parlakpinar, G. Gulbas, N. Vardi, A. Polat, A. Cetin, T. Kilic, and Z.A. Aytemur. 2013. Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology. doi:10.1007/s 00210-013-0908.
13. Sun, A., Q. Sun, and R. Liu. 2006. Spectroscopic investigation of the interaction between chrysin and bovine serum albumin. Chinese Journal of Analytical Chemistry 34: 243–246.
14. Editorial committee of the pharmacopoeia of People's Republic of China, Pharmacopoeia of People's Republic of China (part one), Chemical Industry Press, Beijing, 1999, p. 48.
15. Wang, X., and M.E. Morris. 2007. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG 2. Drug Metabolism and Disposition 35: 268–274.
16. Zheng, X., W.D. Meng, Y.Y. Xu, J.G. Cao, and F.L. Qing. 2003. Synthesis and anticancer effect of chrysin derivatives. Bioorganic and Medicinal Chemistry Letters 13: 881–884.
17. Cho, H., C.W. Yun, and W.K. Park. 2004. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacological Research 49: 37–43.
18. Rice-Evans, C.A. 2001. Flavonoid antioxidants. Current Medicinal Chemistry 8: 797–807.
19. Ha, S.K., E. Moon, and S.Y. Kim. 2010. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-kappaB and JNK activations in microglia cells. Neuroscience Letters 485: 143–147.
20. Mungunsukh, O., A.J. Griffin, Y.H. Lee, and R.M. Day. 2010. Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: 696–703.
21. Pushpavalli, G., P. Kalaiarasi, C. Veeramani, and K.V. Pugalendi. 2010. Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. European Journal of Pharmacology 631: 36–41.
22. Yagi, K. 1998. Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biology 108: 101–106.
23. Sedlak, J., and R.H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry 25: 192–205.
24. Sun, Y., L.W. Oberley, and Y.A. Li. 1988. Simple method for clinical assay of superoxide dismutase. ClinChem 34: 497–500.
25. Aebi, H. 1974. Catalase. In Methods of enzymatic analysis, ed. H.U. Bergmeyer, 673–677. New York: Academic.
26. Paglia, D.E., and W.N. Valentine. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70(1): 158–169.
27. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193:265–275.
28. Sparreboom, A., M.C. Cox, M.R. Acharya, and W.D. Figg. 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. Journal of Clinical Oncology 22: 2489–2503.
29. Middleton, E.J., C. Kandaswami, and T.C. Theoharides. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacological Reviews 52: 673–751.
30. Sleijfer, S. 2001. Bleomycin-induced pneumonitis. Chest 120: 617–624.
31. Chaudhary, N.I., A. Schnapp, and J.E. Park. 2006. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. American Journal of Respiratory and Critical Care Medicine 35(173): 769–776.
32. Mouratis, M.A., and V. Aidinis. 2011. Modeling pulmonary fibrosis with bleomycin. Current Opinion in Pulmonary Medicine 17: 355–361.
33. Valko, M., D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser. 2007. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 39: 44–84.
34. MacNee, W., and I. Rahman. 1995. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50: 53–58.
35. Sheela, C.G., and K.T. Angusti. 1995. Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn. and gugulipid in cholesterol diet fed rats. Indian Journal of Experimental Biology 33: 337–341.
36. Sultana, S., K. Verma, and R. Khan. 2012. Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. Journal of Pharmacy and Pharmacology 64: 872–881.
37. Wang, W., and R. Ballatori. 1998. Endogenous glutathione conjugates occurrence and biological functions. Pharmacological Reviews 32: 335–356.
38. Kinnula, V.L., J.D. Crapo, and K.O. Raivio. 1995. Generation and disposal of reactive oxygen metabolites in the lung. Laboratory Investigation 73: 3–19.
39. Liang, Y.-C., S.-H. Tsai, D.-C. Tsai, S.-Y. Lin-Shiau, and J.-K. Lin. 2001. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-by flavonoids in mouse macrophages. FEBS Letters 496: 12–18.
40. Sagrista, M.L., A.E. Garcia, M. Africa De Madariaga, et al. 2002. Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-l-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radical Research 36: 329–340.
41. Coward, W.R., G. Saini, and G. Jenkins. 2010. The pathogenesis of idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease 4: 367–388.